MedRhythms is the developer of a digital therapeutics platform to deliver rhythmic auditory stimulation therapy to chronic stroke survivors. While RAS therapy typically takes place in a clinical setting, MedRhythms’s product will provide the same experience in the patient’s home. This project provided the Company with working capital to continue MedRhythm’s growth in Maine.